One report illustrates that the administration of nano-curcumin can accelerate recovery from the acute inflammatory phase of COVID-19 by mediating inflammatory immune responses (decrease in serum IFN-γ and IL-17, TBX21 mRNA; increase in serum IL-4 and TGF-β, FOXP3 mRNA) (Ahmadi et al., 2021). The gene discussed is IFNG; the disease is COVID-19.